SNCA and Parkinson disease: Furthermore, the loss or mutation of VPS35 promotes LAMP2A degradation, hampering CMA, and consequently exacerbates the accumulation of α-synuclein in DAergic neurons, thereby contributing to PD pathogenesis [153].